3,4-dihydroxybenzohydroxamic acid has been researched along with stilbenes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Latif, GA; Abdel-Naim, AB; Al-Abbasi, FA; Al-Abd, AM; Khalifa, AE; Tadros, MG | 1 |
1 other study(ies) available for 3,4-dihydroxybenzohydroxamic acid and stilbenes
Article | Year |
---|---|
The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Receptor, ErbB-2; Resveratrol; Stilbenes; Trastuzumab | 2015 |